Virtual screening of imidazole analogs as potential hepatitis C virus NS5B polymerase inhibitors

Chemical Papers

Volumn 67, Issue 2, 2013, Pages 236-244

  Patil, Vaishali M ^a   Gupta, Satya P ^b   Samanta, Subeer ^c   Masand, Neeraj ^d  

^a BHARAT INSTITUTE OF TECHNOLOGY   (India)

^b MEERUT INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

^c BIRLA INSTITUTE OF TECHNOLOGY   (India)

^d LLRM MEDICAL COLLEGE   (India)

Author keywords

anti HCV; FlexX docking; NS5B polymerase; virtual screening

Indexed keywords

EID: 84874483771     PISSN: 03666352     EISSN: 13369075     Source Type: Journal    
DOI: 10.2478/s11696-012-0241-4     Document Type: Article

References (40)

1. Anilkumar, G. N.; Selyutin, O.; Rosenblum, S. B.; Zeng, Q. B.; Jiang, Y. H.; Chan, T. Y.; Pu, H. Y.; Wang, L.; Bennett, F.; Chen, K. X.; Lesburg, C. A.; Duca, J. S.; Gavalas, S.; Huang, Y. H.; Pinto, P.; Sannigrahi, M.; Velazquez, F.; Venkataraman, S.; Vilbubhan, B.; Agrawal, S.; Ferrari, E.; Jiang, C. K.; Huang, H. C.; Shih, N. Y.; Njoroge, F. G.; & Kozlowski, J. A. (2012). II. Novel HCV NS5B polymerase inhibitors: Discovery of indole C2 aryl sulfonamides. Bioorganic & Medicinal Chemistry Letters, 22, 713-717. DOI: 10.1016/j.bmcl.2011.10.041.
2. Beaulieu, P. L. (2007). Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections. Current Opinion in Investigational Drugs, 8, 614-634. (Pubitemid 47205246)
3. Beaulieu, P. L.; Bös, M.; Bousquet, Y.; DeRoy, P.; Fazal, G.; Gauthier, J.; Gillard, J.; Goulet, S.; McKercher, G.; Poupart, M. A.; Valois, S.; & Kukolj, G. (2004). Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency. Bioorganic & Medicinal Chemistry Letters, 14, 967-971. DOI: 10.1016/j.bmcl.2003.12.032. (Pubitemid 38167623)
4. Behrens, S. E.; Tomei, L.; & De Francesco, R. (1996). Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. The EMBO Journal, 15, 12-22. (Pubitemid 26020384)
5. BioSolveIT (2012). FlexX [computer software]. Sankt Augustin, Germany: BioSolveIT. www.biosolveit.de
6. Biswal, B. K.; Cherney, M. M.; Wang, M.; Chan, L.; Yannopoulos, C. G.; Bilimoria, D.; Nicolas, O.; Bedard, J.; & James, M. N. (2005). Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by nonnucleoside inhibitors. The Journal of Biological Chemistry, 280, 18202-18210. DOI: 10.1074/jbc.m413410200. (Pubitemid 41389065)
7. Böhm, H. J. (1992). The computer program LUDI: A new method for the de novo design of enzyme inhibitors. Journal of Computer-Aided Molecular Design, 6, 61-78. DOI: 10.1007/bf00124387.
8. Bressanelli, S.; Tomei, L.; Rey, F. A.; & De Francesco, R. (2002). Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides. Journal of Virology, 76, 3482-3492. DOI: 10.1128/jvi.76.7.3482- 3492.2002. (Pubitemid 34224549)
9. Chan, L.; Reddy, T. J.; Proulx, M.; Das, S. K.; Pereira, O.; Wang, W. Y.; Siddiqui, A.; Yannopoulos, C. G.; Poisson, C.; Turcotte, N.; Drouin, A.; Alaoui-Ismaili, M. H.; Bethell, R.; Hamel, M.; L'Heureux, L.; Bilimoria, D.; & Nguyen-Ba, N. (2003). Identification of N,N-disubstituted phenylalanines as a novel class of inhibitors of hepatitis C NS5B polymerase. Journal of Medicinal Chemistry, 46, 1283-1285. DOI: 10.1021/jm0340400. (Pubitemid 36512692)
10. Chan, L.; Pereira, O.; Reddy, T. J.; Das, S. K.; Poisson, C.; Courchesne, M.; Proulx, M.; Siddiqui, A.; Yannopoulos, C. G.; Nguyen-Ba, N.; Roy, C.; Nasturica, D.; Moinet, C.; Bethell, R.; Hamel, M.; L'Heureux, L.; David, M.; Nicolas, O.; Courtemanche-Asselin, P.; Brunette, S.; Bilimoria, D.; & Bedard, J. (2004). Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: Tertiary amides. Bioorganic & Medicinal Chemistry Letters, 14, 797-800. DOI: 10.1016/j.bmcl.2003.10.068. (Pubitemid 38114874)
11. Di Marco, S.; Volpari, C.; Tomei, L.; Altamura, S.; Harper, S.; Narjes, F.; Koch, U.; Rowley, M.; De Francesco, R.; Migliaccio, G.; & Carfí, A. (2005). Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site. The Journal of Biological Chemistry, 280, 29765-29770. DOI: 10.1074/jbc.m505423200. (Pubitemid 41177053)
12. Doman, T. N.; McGovern, S. L.; Witherbee, B. J.; Kasten, T. P.; Kurumbail, R.; Stallings, W. C.; Connolly, D. T.; & Shoichet, B. K. (2002). Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. Journal of Medicinal Chemistry, 45, 2213-2221. DOI: 10.1021/jm010548w. (Pubitemid 34525801)
13. Gopalsamy, A.; Lim, K. T.; Ciszewski, G.; Park, K.; Ellingboe, J. W.; Bloom, J.; Insaf, S.; Upeslacis, J.; Mansour, T. S.; Krishnamurthy, G.; Damarla, M.; Pyatski, Y.; Ho, D.; Howe, A. Y. M.; Orlowski, M.; Feld, B.; & O'Connell, J. (2004). Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors. Journal of Medicinal Chemistry, 47, 6603-6608. DOI: 10.1021/jm0401255. (Pubitemid 39657321)
14. Guido, R. V. C.; Oliva, G.; & Andricopulo, A. D. (2008). Virtual screening and its integration with modern drug design technologies. Current Medicinal Chemistry, 15, 37-46. DOI: 10.2174/092986708783330683. (Pubitemid 351234626)
15. Gupta, S. P.; Samanta, S.; & Patil, V. M. (2010). A 3D-QSAR study on a series of benzimidazole derivatives acting as hepatitis C virus inhibitors: application of kNN-molecular field analysis. Medicinal Chemistry, 6, 87-90.
16. Ikegashira, K.; Oka, T.; Hirashima, S.; Noji, S.; Yamanaka, H.; Hara, Y.; Adachi, T.; Tsuruha, J. I.; Doi, S.; Hase, Y.; Noguchi, T.; Ando, I.; Ogura, N.; Ikeda, S.; & Hashimoto, H. (2006). Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors. Journal of Medicinal Chemistry, 49, 6950-6953. DOI: 10.1021/jm0610245. (Pubitemid 44885982)
17. Kaushik-Basu, N.; Bopda-Waffo, A.; Talele, T. T.; Basu, A.; Chen, Y.; & Kucukguzel, S. G. (2008a). 4-Thiazolidinones: a novel class of hepatitis C virus NS5B polymerase inhibitors. Frontiers in Bioscience, 13, 3857-3868. DOI: 10.2741/2974. (Pubitemid 351594665)
18. Kaushik-Basu, N.; Bopda-Waffo, A.; Talele, T. T.; Basu, A.; Costa, P. R. R.; da Silva, A. J. M.; Sarafianos, S. G.; Noël, F. (2008b). Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors. Nucleic Acids Research, 36, 1482-1496. DOI: 10.1093/nar/gkm1178. (Pubitemid 351426102)
19. Koch, U.; & Narjes, F. (2007). Recent progress in the development of inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. Current Topics in Medicinal Chemistry, 7, 1302-1329. (Pubitemid 47321576)
20. Kumar, D. V.; Rai, R.; Brameld, K. A.; Somoza, J. R.; Rajagopalan, R.; Janc, J. W.; Xia, Y. M.; Ton, T. L.; Shaghafi, M. B.; Hu, H. Y.; Lehoux, I.; To, N.; Young, W. B.; & Green, M. J. (2011). Quinolones as HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters, 21, 82-87. DOI: 10.1016/j.bmcl.2010.11.068.
21. Li, H.; Tatlock, J.; Linton, A.; Gonzalez, J.; Borchardt, A.; Dragovich, P.; Jewell, T.; Prins, T.; Zhou, R.; Blazel, J.; Parge, H.; Love, R.; Hickey, M.; Doan, C.; Shi, S.; Duggal, R.; Lewis, C.; & Fuhrman, S. (2006). Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters, 16, 4834-4838. DOI: 10.1016/j.bmcl.2006.06.065. (Pubitemid 44175854)
22. Love, R. A.; Parge, H. E.; Yu, X.; Hickey, M. J.; Diehl, W.; Gao, J. J.; Wriggers, H.; Ekker, A.; Wang, L.; Thomson, J. A.; Dragovich, P. S.; & Fuhrman, S. A. (2003). Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme. Journal of Virology, 77, 7575-7581. DOI: 10.1128/jvi.77.13.7575-7581.2003. (Pubitemid 36734527)
23. Lyne, P. D. (2002). Structure-based virtual screening: an overview. Drug Discovery Today, 7, 1047-1055. DOI: 10.1016/s1359-6446(02)02483-2.
24. Lyne, P. D.; Kenny, P.W.; Cosgrove, D. A.; Deng, C.; Zabludoff, S.; Wendoloski, J. J.; & Ashwell, S. J. (2004). Identification of compounds with nanomolar binding affinity for checkpoint kinase-1 using knowledge-based virtual screening. Journal of Medicinal Chemistry, 47, 1962-1968. DOI: 10.1021/jm030504i. (Pubitemid 38453915)
25. Moradpour, D.; Penin, F.; & Rice, C. M. (2007). Replication of hepatitis C virus. Nature Reviews Microbiology, 5, 453-463. DOI: 10.1038/nrmicro1645. (Pubitemid 46780082)
26. Ontoria, J. M.; Martín Hernando, J. I.; Malancona, S.; Attenni, B.; Stansfield, I.; Conte, I.; Ercolani, C.; Habermann, J.; Ponzi, S.; Di Filippo, M.; Koch, U.; Rowley, M.; & Narjes, F. (2006). Identification of thieno[3,2-b]pyrroles as allosteric inhibitors of hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters, 16, 4026-4030. DOI: 10.1016/j.bmcl.2006.05.012. (Pubitemid 43903215)
27. Patel, P. D.; Patel, M. R.; Kaushik-Basu, N.; & Talele, T. T. (2008). 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors. Journal of Chemical Information and Modeling, 48, 42-55. DOI: 10.1021/ci700266z. (Pubitemid 351271049)
28. Patil, V. M.; Gupta, S. P.; & Samanta, S. (2010). A QSAR study on some series of anti-hepatitis C virus (HCV) agents. Letters in Drug Design & Discovery, 7, 139-148. DOI: 10.2174/157018010790225877.
29. Patil, V. M.; Gupta, S. P.; Samanta, S.; & Masand, N. (2011). 3D QSAR kNN-MFA studies on thiouracil derivatives as hepatitis C virus inhibitors. Medicinal Chemistry Research, 20, 1616-1621. DOI: 10.1007/s00044-010-9435-x.
30. Powers, J. P.; Piper, D. E.; Li, Y.; Mayorga, V.; Anzola, J.; Chen, J. M.; Jaen, J. C.; Lee, G.; Liu, J. Q.; Peterson, M. G.; Tonn, G. R.; Ye, Q. P.; Walker, N. P. C.; & Wang, Z. L. (2006). SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase. Journal of Medicinal Chemistry, 49, 1034-1046. DOI: 10.1021/jm050859x. (Pubitemid 43221651)
31. Rarey, M.; Kramer, B.; Lengauer, T.; & Klebe, G. (1996). A fast flexible docking method using an incremental construction algorithm, Journal of Molecular Biology, 261, 470-489. DOI: 10.1006/jmbi.1996.0477. (Pubitemid 26335901)
32. Rarey, M.; Kramer, B.; & Lengauer, T. (1997). Multiple automatic base selection: Protein-ligand docking based on incremental construction without manual intervention. Journal of Computer Aided Molecular Design, 11, 369-384. DOI: 10.1023/a:1007913026166. (Pubitemid 127506743)
33. Rester, U. (2008). From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective. Current Opinion in Drug Discovery & Development, 11, 559-568. (Pubitemid 351950850)
34. Rong, F.; Chow, S. Y.; Yan, S. Q.; Larson, G.; Hong, Z.; & Wu, J. (2007). Structure-activity relationship (SAR) studies of quinoxalines as novel HCV NS5B RNA-dependent RNA polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters, 17, 1663-1666. DOI: 10.1016/j.bmcl.2006.12.103. (Pubitemid 46274352)
35. Shaw, A. N.; Tedesco, R.; Bambal, R.; Chai, D. P.; Concha, N. O.; Darcy, M. G.; Dhanak, D.; Duffy, K. J.; Fitch, D. M.; Gates, A.; Johnston, V. K.; Keenan, R. M.; Lin-Goerke, J.; Liu, N. N.; Sarisky, R. T.; Wiggall, K. J.; & Zimmerman, M. N. (2009). Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase. Bioorganic & Medicinal Chemistry Letters, 19, 4350-4353. DOI: 10.1016/j.bmcl.2009.05.091.
36. Soriano, V.; Peters, M. G.; & Zeuzem, S. (2009). New therapies for hepatitis C virus infection. Clinical Infectious Diseases, 48, 313-320. DOI: 10.1086/595848.
37. Talele, T. T. (2008). Multiple allosteric pockets of HCV NS5B polymerase and its inhibitors: A structure based insight. Current Bioactive Compounds, 4, 86-109. DOI: 10.2174/157340708785294217.
38. Tedesco, R.; Shaw, A. N.; Bambal, R.; Chai, D. P.; Concha, N. O.; Darcy, M. G.; Dhanak, D.; Fitch, D. M.; Gates, A.; Gerhardt, W. G.; Halegoua, D. L.; Han, C.; Hofmann, G. A.; Johnston, V. K.; Kaura, A. C.; Liu, N. N.; Keenan, R. M.; Lin-Goerke, J.; Sarisky, R. T.; Wiggall, K. J.; Zimmerman, M. N.; & Duffy, K. J. (2006). 3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy- 2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase. Journal of Medicinal Chemistry, 49, 971-983. DOI: 10.1021/jm050855s. (Pubitemid 43221645)
39. Wang, Q. M.; & Heinz, B. A. (2000). Recent advances in prevention and treatment of hepatitis C virus infections. Progress in Drug Research, 55, 1-32. DOI: 10.1007/978-3-0348-8385-61.
40. Yan, S. Q.; Appleby, T.; Larson, G.; Wu, J. Z.; Hamatake, R.; Hong, Z.; & Yao, N. H. (2006). Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors. Bioorganic & Medicinal Chemistry Letters, 16, 5888-5891. DOI: 10.1016/j.bmcl.2006.08.056. (Pubitemid 44486727)